Show simple item record

dc.contributor.authorTalaie, Tara
dc.contributor.authorDiChiacchio, Laura
dc.contributor.authorPrasad, Nikhil K
dc.contributor.authorPasrija, Chetan
dc.contributor.authorJulliard, Walker
dc.contributor.authorKaczorowski, David J
dc.contributor.authorZhao, Yunge
dc.contributor.authorLau, Christine L
dc.date.accessioned2021-04-27T18:31:07Z
dc.date.available2021-04-27T18:31:07Z
dc.date.issued2021-01-07
dc.identifier.urihttp://hdl.handle.net/10713/15518
dc.description.abstractLung ischemia-reperfusion injury (LIRI) and primary graft dysfunction are leading causes of morbidity and mortality among lung transplant recipients. Although extensive research endeavors have been undertaken, few preventative and therapeutic treatments have emerged for clinical use. Novel strategies are still needed to improve outcomes after lung transplantation. In this review, we discuss the underlying mechanisms of transplanted LIRI, potential modifiable targets, current practices, and areas of ongoing investigation to reduce LIRI and primary graft dysfunction in lung transplant recipients. © 2021 Lippincott Williams and Wilkins. All rights reserved.en_US
dc.description.urihttps://doi.org/10.1097/TXD.0000000000001104en_US
dc.language.isoenen_US
dc.publisherWolters Kluwer Healthen_US
dc.relation.ispartofTransplantation Directen_US
dc.rightsCopyright © 2020 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.en_US
dc.subject.meshLung Transplantationen_US
dc.subject.meshReperfusion Injuryen_US
dc.titleIschemia-reperfusion Injury in the Transplanted Lung: A Literature Reviewen_US
dc.typeArticleen_US
dc.identifier.doi10.1097/TXD.0000000000001104
dc.identifier.pmid33437867
dc.source.volume7
dc.source.issue2
dc.source.beginpagee652
dc.source.endpage
dc.source.countryUnited States


This item appears in the following Collection(s)

Show simple item record